Open AccessLong-term survival of a feline with non-T/B large granular lymphocyte lymphoma treated with chemotherapy and activated lymphocyte therapy
Author(s) -
Shimon Furusato,
Yu Tamura,
James Chambers,
Takahiro Ushigusa,
Yu Tsuyama
Publication year - 2022
Publication title -
open veterinary journal
Language(s) - English
Resource type - Journals
eISSN - 2226-4485
pISSN - 2218-6050
DOI - 10.5455/ovj.2022.v12.i3.2
Subject(s) - medicine , vincristine , chemotherapy , lymphocyte , lymphoma , prednisolone , canine lymphoma , cyclophosphamide , immunology , gastroenterology , pathology
Feline large granular lymphocyte lymphoma (LGLL) is a grave prognosis. However, the effectiveness of concurrent treatment with chemotherapy and activated lymphocyte therapy for feline LGLL has not been evaluated.